316 related articles for article (PubMed ID: 17981535)
1. Interleukin-17: a novel inflammatory cytokine that bridges innate and adaptive immunity.
Yu JJ; Gaffen SL
Front Biosci; 2008 Jan; 13():170-7. PubMed ID: 17981535
[TBL] [Abstract][Full Text] [Related]
2. The IL-17 cytokine family.
Gaffen SL; Kramer JM; Yu JJ; Shen F
Vitam Horm; 2006; 74():255-82. PubMed ID: 17027518
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-17 family cytokines in protective immunity against infections: role of hematopoietic cell-derived and non-hematopoietic cell-derived interleukin-17s.
Matsuzaki G; Umemura M
Microbiol Immunol; 2018 Jan; 62(1):1-13. PubMed ID: 29205464
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-17 and its expanding biological functions.
Xu S; Cao X
Cell Mol Immunol; 2010 May; 7(3):164-74. PubMed ID: 20383173
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-17A in lipid metabolism and atherosclerosis.
Yu XH; Jiang N; Zheng XL; Cayabyab FS; Tang ZB; Tang CK
Clin Chim Acta; 2014 Apr; 431():33-9. PubMed ID: 24508995
[TBL] [Abstract][Full Text] [Related]
6. IL-17/Th17 targeting: on the road to prevent chronic destructive arthritis?
Lubberts E
Cytokine; 2008 Feb; 41(2):84-91. PubMed ID: 18039580
[TBL] [Abstract][Full Text] [Related]
7. Structure and signalling in the IL-17 receptor family.
Gaffen SL
Nat Rev Immunol; 2009 Aug; 9(8):556-67. PubMed ID: 19575028
[TBL] [Abstract][Full Text] [Related]
8. Cytokine networking of innate immunity cells: a potential target of therapy.
Striz I; Brabcova E; Kolesar L; Sekerkova A
Clin Sci (Lond); 2014 May; 126(9):593-612. PubMed ID: 24450743
[TBL] [Abstract][Full Text] [Related]
9. Dysregulation of innate immunity in ulcerative colitis patients who fail anti-tumor necrosis factor therapy.
Baird AC; Mallon D; Radford-Smith G; Boyer J; Piche T; Prescott SL; Lawrance IC; Tulic MK
World J Gastroenterol; 2016 Nov; 22(41):9104-9116. PubMed ID: 27895398
[TBL] [Abstract][Full Text] [Related]
10. An Overview of Interleukin-17A and Interleukin-17 Receptor A Structure, Interaction and Signaling.
Krstic J; Obradovic H; Kukolj T; Mojsilovic S; Okic-Dordevic I; Bugarski D; Santibanez JF
Protein Pept Lett; 2015; 22(7):570-8. PubMed ID: 25990083
[TBL] [Abstract][Full Text] [Related]
11. A bone-protective role for IL-17 receptor signaling in ovariectomy-induced bone loss.
Goswami J; Hernández-Santos N; Zuniga LA; Gaffen SL
Eur J Immunol; 2009 Oct; 39(10):2831-9. PubMed ID: 19731364
[TBL] [Abstract][Full Text] [Related]
12. Innate and adaptive interleukin-17-producing lymphocytes in chronic inflammatory lung disorders.
Vanaudenaerde BM; Verleden SE; Vos R; De Vleeschauwer SI; Willems-Widyastuti A; Geenens R; Van Raemdonck DE; Dupont LJ; Verbeken EK; Meyts I
Am J Respir Crit Care Med; 2011 Apr; 183(8):977-86. PubMed ID: 21097694
[TBL] [Abstract][Full Text] [Related]
13. Th17 cytokines and their emerging roles in inflammation and autoimmunity.
Fouser LA; Wright JF; Dunussi-Joannopoulos K; Collins M
Immunol Rev; 2008 Dec; 226():87-102. PubMed ID: 19161418
[TBL] [Abstract][Full Text] [Related]
14. Induction, function and regulation of IL-17-producing T cells.
Mills KH
Eur J Immunol; 2008 Oct; 38(10):2636-49. PubMed ID: 18958872
[TBL] [Abstract][Full Text] [Related]
15. Interluekin-17A (IL17A).
Chen K; Kolls JK
Gene; 2017 May; 614():8-14. PubMed ID: 28122268
[TBL] [Abstract][Full Text] [Related]
16. Biology of recently discovered cytokines: interleukin-17--a unique inflammatory cytokine with roles in bone biology and arthritis.
Gaffen SL
Arthritis Res Ther; 2004; 6(6):240-7. PubMed ID: 15535837
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-17: a new paradigm in inflammation, autoimmunity, and therapy.
Kramer JM; Gaffen SL
J Periodontol; 2007 Jun; 78(6):1083-93. PubMed ID: 17539723
[TBL] [Abstract][Full Text] [Related]
18. IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential.
Zhu S; Qian Y
Clin Sci (Lond); 2012 Jun; 122(11):487-511. PubMed ID: 22324470
[TBL] [Abstract][Full Text] [Related]
19. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor signaling and regulation of cytokine gene expression in the immune system.
Ozato K; Tsujimura H; Tamura T
Biotechniques; 2002 Oct; Suppl():66-8, 70, 72 passim. PubMed ID: 12395929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
